Publications by authors named "Kevin Bahnck"

Claim this Profile
O
Optimization of amide-based EP3 receptor antagonists.
Esther C Y Lee, Kentaro Futatsugi, Joel T Arcari, Kevin Bahnck, Steven B Coffey

Bioorg Med Chem Lett· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family.
Kim Huard, James R Gosset, Justin I Montgomery, Adam Gilbert, Matthew M Hayward, Kevin Bahnck

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.
Kim Huard, Allyn T Londregan, Gregory Tesz, Kevin B Bahnck, Thomas V Magee

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of sulfones from organozinc reagents, DABSO, and alkyl halides.
Benjamin N Rocke, Kevin B Bahnck, Michael Herr, Sophie Lavergne, Vincent Mascitti

Org Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.
Benjamin D Stevens, John Litchfield, Jeffrey A Pfefferkorn, Karen Atkinson, Christian Perreault, Kevin Bahnck

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure.
David A Griffith, Robert L Dow, Kim Huard, David J Edmonds, Scott W Bagley, Kevin B Bahnck

J Med Chem· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119.
Etzer Darout, Ralph P Robinson, Kim F McClure, Matthew Corbett, Bryan Li, Kevin B Bahnck

J Med Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indolynes as electrophilic indole surrogates: fundamental reactivity and synthetic applications.
Sarah M Bronner, Kevin B Bahnck, Neil K Garg

Org Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formal synthesis of (-)-kendomycin featuring a Prins-cyclization to construct the macrocycle.
Kevin B Bahnck, Scott D Rychnovsky

J Am Chem Soc· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piperazinyl CCR1 antagonists--optimization of human liver microsome stability.
Matthew F Brown, Kevin B Bahnck, Laura C Blumberg, William H Brissette, Sara A Burrell

Bioorg Med Chem Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid stereocontrolled assembly of the fully substituted C-aryl glycoside of kendomycin with a Prins cyclization: a formal synthesis.
Kevin B Bahnck, Scott D Rychnovsky

Chem Commun (Camb)· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bond insertion, complexation, and penetration pathways of vapor-deposited aluminum atoms with HO- and CH(3)O-terminated organic monolayers.
Gregory L Fisher, Amy V Walker, Andrew E Hooper, Timothy B Tighe, Kevin B Bahnck

J Am Chem Soc· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis